SEC SCHEDULE 13G

Company

Xenon Pharmaceuticals Inc.

Filed

February 8, 2024

Accession Number

0000902219-24-000018

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →